Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients
10.1046/j.1365-2125.2003.01767.x
Saved in:
Main Authors: | Lee, H.S., Goh, B.C., Fan, L., Khoo, Y.M., Wang, L., Lim, R., Ong, A.B., Chua, C. |
---|---|
其他作者: | PHARMACY |
格式: | Article |
出版: |
2014
|
主題: | |
在線閱讀: | http://scholarbank.nus.edu.sg/handle/10635/106218 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients
由: Lee, H.S., et al.
出版: (2012) -
Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug
由: Tham, L.-S., et al.
出版: (2014) -
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
由: Yong, W.-P., et al.
出版: (2014) -
Amineptine and midazolam dependence
由: Perera, I., et al.
出版: (2016) -
The use of midazolam and haloperidol in cancer patients at the end of life
由: Radha Krishna, L.K., et al.
出版: (2016)